Business
VivoSim Labs, INC.: our business strategies; customer acceptance and the market potential of our technology; products and services; our future capital requirements; our future financial performance; and other matters.
Revenue increased 32.1% to $144.0K, while Net income increased 83.0% to ($2.5M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $144.0KWatch
- Profitability — Net income ($2.5M)Watch
- Cash generation — Free cash flow ($9.5M)Note
- Accounting — Formula distress score · manipulation flag raised · earnings quality weakWatch
- Insiders — 0 buys; 1 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Where the revenue comes from
Fiscal 2026, as VivoSim Labs, INC. reports it. History and quarterly detail are in the app.
- Sales Based Royalties$131K
- Royalty$131K
Leadership changes
From VivoSim Labs, INC.'s own filings, the day they're filed.
- Tony Lialin · Chief Commercial Officer · appointmenteff. 2025-08-11
- Vaidehi Joshi · Directors · departureeff. 2025-03-21
- Norman Staskey · Chief Financial Officer · departureeff. 2024-12-30
Latest filings
- 8-K · Company announcement2026-08-21
- DEF 14A · Annual proxy (pay & governance)2026-08-21
- 10-Q · Quarterly report2026-08-12
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about VivoSim Labs, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.